GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » Issuance of Debt

Scinopharm Taiwan (TPE:1789) Issuance of Debt : NT$51 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Scinopharm Taiwan Issuance of Debt?

Scinopharm Taiwan's Issuance of Debt for the three months ended in Mar. 2024 was NT$0 Mil.

Scinopharm Taiwan's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 was NT$51 Mil.

Scinopharm Taiwan Issuance of Debt Historical Data

The historical data trend for Scinopharm Taiwan's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scinopharm Taiwan Issuance of Debt Chart

Scinopharm Taiwan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 185.70 89.27 - 77.22 63.47

Scinopharm Taiwan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.70 -7.66 58.24 0.06 -

Scinopharm Taiwan Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scinopharm Taiwan Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Scinopharm Taiwan's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Scinopharm Taiwan (TPE:1789) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » Issuance of Debt
Comparable Companies
ROCO:4105 TPE:1707 ROCO:6620 ROCO:4114 TPE:3705 ROCO:6785 ROCO:6576 TPE:1720 TPE:4746 ROCO:4123 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 1, Nan-Ke 8th Road, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144
Website
https://www.scinopharm.com
Scinopharm Taiwan Ltd is a specialty and generic drug manufacturing company. The company is primarily engaged in the manufacturing of medicines, chemicals, biological technology services, active pharmaceutical ingredients, albumin medicines, injections, and new small molecule drugs. Schinopharm also conducts consulting and technical services. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Scinopharm Taiwan (TPE:1789) Headlines

No Headlines